Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients

Within the multicenter SUCCESS trial, we investigated the association of plasma microRNAs with different subtypes of invasive breast cancer. Six miRs (miR-16, miR-27a, miR-107, miR-130a, miR-132 and miR-146a) were selected from microarray profiling and further validated in plasma of 111 breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Stückrath, Isabel, Rack, Brigitte, Janni, Wolfgang, Jäger, Bernadette, Pantel, Klaus, Schwarzenbach, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537022/
https://www.ncbi.nlm.nih.gov/pubmed/26033453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537022/
https://www.ncbi.nlm.nih.gov/pubmed/26033453

Ejemplares similares